Microbial production of steviol glycosides
Inventors
PHILIPPE, Ryan • KUMARAN, Ajikumar Parayil • Donald, Jason • PATEL, Krishna • Gupta, Swati • LIM, Ryan • Li, Liwei
Assignees
Interested in licensing this patent?
MTEC can help explore whether this patent might be available for licensing for your application.
Abstract
The invention provides methods for making steviol glycosides, including RebM and glycosylation products that are minor products in stevia leaves, and provides enzymes, encoding polynucleotides, and host cells for use in these methods. The invention provides engineered enzymes and engineered host cells for producing steviol glycosylation products, such as RebM, at high purity and/or yield. The invention further provides methods of making products containing steviol glycosides, such as RebM, including food products, beverages, oral care products, sweeteners, and flavoring products.
Core Innovation
The claims describe methods for producing Rebaudioside M (RebM) and other steviol glycosides using an engineered E. coli host expressing recombinant uridine diphosphate-dependent glycosyltransferase enzymes. These enzymes catalyze 13-O glycosylation, 19-O glycosylation, and 1-2′ and 1-3′ glycosylation at C-19 and C-13 on steviol or steviol glycoside substrates. The host further comprises genetic modifications that increase UDP-glucose production, and RebM is transported into the culture medium for recovery.
The screening results report variant-dependent changes in glycosylation activity, upstream pathway components, improved steviol-glycoside conversion including RebA-to-RebD and RebD-to-RebM, and elevated kaurene and steviol titers. Disclosures also report increased steviol production with engineered AtKAH alongside host-pathway optimization, with RebM accumulating predominantly extracellularly in commercial-scale cultures. Because the background section is omitted from the supplied content, the specific technical problem being solved is not explicitly described.
Claims Coverage
The claims identify two independent claims covering four inventive features for Rebaudioside M (RebM) production in an engineered E. coli host.
UGT-mediated glycosylation
Both independent claims specify an E. coli host expressing recombinant UGT enzymes that catalyze 13-O glycosylation, 19-O glycosylation, 1-2′ glycosylation at C-19 and C-13, and 1-3′ glycosylation at C-19 and C-13 on steviol or steviol glycoside substrates.
Host genetic modifications increasing UDP-glucose production
One independent claim specifies one or more genetic modifications to the E. coli host that increase UDP-glucose production.
Transport and recovery of RebM
Both independent claims specify that RebM is transported into the culture medium and recovered from that medium [procedural detail omitted for safety].
Specified culture scale
One independent claim specifies RebM production in a culture at a scale of at least 1,000 L [procedural detail omitted for safety].
Together, the independent claims cover enzymatic glycosylation and extracellular recovery of RebM in E. coli, with one claim requiring increased UDP-glucose production and the other specifying a culture scale of at least 1,000 L.
Stated Advantages
Screening results demonstrate improved conversion for selected UGT variants, increased steviol production with engineered AtKAH, and elevated kaurene and steviol titers relative to compared variants or controls.
The figure descriptions report that more than 90% of RebM accumulates extracellularly as the dominant product.
Selected variants exhibit increased steviol glycoside product signals relative to controls, including RebM formation by a 76G1 lead.
Documented Applications
Production of Rebaudioside M (RebM) using an engineered E. coli host expressing recombinant UGT enzymes and pathway components, with RebM transported into the culture medium and recovered.
Incorporation of RebM into products, as identified in the claim-family summary without specifying the products.
Interested in licensing this patent?